836 GENES FOUNDi

Show / hide columns

XML | RDF | TSV | Page of 17 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

B4GALNT3Beta-1,4-N-acetyl-galactosaminyl transferase 3Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Vesicles
Endometrial cancer: 1.69e-10
Tissue enhanced
P2RX4Purinergic receptor P2X, ligand gated ion channel, 4Predicted membrane proteins
Transporters
Actin filaments
Cytosol
Endometrial cancer: 6.30e-10
Mixed
SPDEFSAM pointed domain containing ETS transcription factorPredicted intracellular proteins
Transcription factors
Nucleus
Nucleoli
Endometrial cancer: 9.26e-9
Tissue enhanced
SCGB2A1Secretoglobin, family 2A, member 1Cancer-related genes
Predicted secreted proteins
Endometrial cancer: 1.54e-8
Colorectal cancer: 1.22e-4
Renal cancer: 6.36e-4
Group enriched
DHRS7BDehydrogenase/reductase (SDR family) member 7BPredicted intracellular proteins
Predicted membrane proteins
Plasma membrane
Cell Junctions
Cytosol
Endometrial cancer: 1.98e-8
Renal cancer: 3.95e-5
Expressed in all
PLPP2Phospholipid phosphatase 2Enzymes
Predicted membrane proteins
MitochondriaEndometrial cancer: 3.21e-8
Breast cancer: 4.55e-4
Tissue enhanced
NXNL2Nucleoredoxin-like 2Predicted intracellular proteins
CytosolEndometrial cancer: 3.83e-8
Breast cancer: 6.53e-4
Renal cancer: 9.60e-4
Mixed
SMDT1Single-pass membrane protein with aspartate-rich tail 1Predicted membrane proteins
Transporters
Nucleus
Mitochondria
Renal cancer: 2.36e-9
Endometrial cancer: 5.32e-8
Pancreatic cancer: 5.87e-4
Expressed in all
SLC47A1Solute carrier family 47 (multidrug and toxin extrusion), member 1Predicted membrane proteins
Transporters
Endometrial cancer: 5.54e-8
Renal cancer: 1.06e-5
Lung cancer: 1.88e-5
Tissue enhanced
HEXAHexosaminidase A (alpha polypeptide)Candidate cardiovascular disease genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted secreted proteins
Endometrial cancer: 5.63e-8
Expressed in all
PGRProgesterone receptorCancer-related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Endometrial cancer: 5.76e-8
Group enriched
STX18Syntaxin 18Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneEndometrial cancer: 6.33e-8
Colorectal cancer: 2.84e-4
Urothelial cancer: 4.69e-4
Renal cancer: 7.03e-4
Expressed in all
ATPIF1ATPase inhibitory factor 1Predicted intracellular proteins
MitochondriaEndometrial cancer: 6.38e-8
Ovarian cancer: 8.20e-4
Expressed in all
DRAM1DNA-damage regulated autophagy modulator 1Predicted intracellular proteins
Predicted membrane proteins
Endometrial cancer: 6.52e-8
Renal cancer: 3.91e-4
Expressed in all
SPAG4Sperm associated antigen 4Predicted intracellular proteins
Predicted membrane proteins
Endometrial cancer: 9.52e-8
Colorectal cancer: 1.09e-5
Glioma: 8.89e-5
Renal cancer: 1.28e-4
Urothelial cancer: 6.66e-4
Mixed
SCGB2A2Secretoglobin, family 2A, member 2Cancer-related genes
Predicted secreted proteins
Endometrial cancer: 9.57e-8
Tissue enriched
ZAP70Zeta-chain (TCR) associated protein kinase 70kDaDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
RAS pathway related proteins
Renal cancer: 3.02e-8
Endometrial cancer: 9.66e-8
Head and neck cancer: 3.93e-6
Cervical cancer: 6.89e-5
Tissue enhanced
GPR108G protein-coupled receptor 108Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatus
Vesicles
Renal cancer: 1.29e-9
Endometrial cancer: 1.04e-7
Expressed in all
MSX1Msh homeobox 1Disease related genes
Predicted intracellular proteins
Transcription factors
NucleoplasmEndometrial cancer: 1.64e-7
Renal cancer: 1.18e-5
Group enriched
SERINC2Serine incorporator 2Predicted membrane proteins
Endometrial cancer: 1.69e-7
Liver cancer: 2.11e-4
Lung cancer: 5.70e-4
Mixed
HMG20BHigh mobility group 20BPredicted intracellular proteins
Transcription factors
NucleoplasmEndometrial cancer: 1.72e-7
Urothelial cancer: 2.89e-5
Expressed in all
CD3DCD3d molecule, delta (CD3-TCR complex)CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Endometrial cancer: 1.73e-7
Renal cancer: 3.07e-5
Cervical cancer: 8.46e-5
Head and neck cancer: 1.70e-4
Breast cancer: 3.00e-4
Urothelial cancer: 6.16e-4
Tissue enhanced
CCDC159Coiled-coil domain containing 159Predicted intracellular proteins
Nucleoplasm
Nuclear bodies
Cytosol
Endometrial cancer: 1.87e-7
Pancreatic cancer: 1.42e-4
Urothelial cancer: 8.62e-4
Ovarian cancer: 9.46e-4
Expressed in all
KIAA1324KIAA1324Predicted membrane proteins
Predicted secreted proteins
Plasma membraneEndometrial cancer: 2.14e-7
Lung cancer: 5.69e-5
Ovarian cancer: 2.16e-4
Mixed
CRELD2Cysteine-rich with EGF-like domains 2Predicted secreted proteins
Renal cancer: 1.34e-9
Endometrial cancer: 2.42e-7
Expressed in all
IER5Immediate early response 5Predicted intracellular proteins
Nucleus
Nucleoli
Endometrial cancer: 2.42e-7
Lung cancer: 1.18e-4
Renal cancer: 2.36e-4
Mixed
SAMM50SAMM50 sorting and assembly machinery componentPredicted intracellular proteins
Transporters
MitochondriaRenal cancer: 4.43e-8
Endometrial cancer: 2.63e-7
Expressed in all
TRPM4Transient receptor potential cation channel, subfamily M, member 4Disease related genes
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Nucleoplasm
Plasma membrane
Renal cancer: 2.53e-7
Endometrial cancer: 2.88e-7
Mixed
C15orf65Chromosome 15 open reading frame 65Cancer-related genes
Predicted intracellular proteins
Nucleus
Cytosol
Endometrial cancer: 3.18e-7
Mixed
VPS39Vacuolar protein sorting 39 homolog (S. cerevisiae)Plasma proteins
Predicted intracellular proteins
Endometrial cancer: 3.21e-7
Expressed in all
SLC25A35Solute carrier family 25, member 35Predicted membrane proteins
Transporters
Vesicles
Mitochondria
Endometrial cancer: 3.37e-7
Renal cancer: 1.14e-6
Urothelial cancer: 1.91e-5
Mixed
KDM4BLysine (K)-specific demethylase 4BPlasma proteins
Predicted intracellular proteins
Nucleus
Cytosol
Endometrial cancer: 4.25e-7
Melanoma: 2.13e-4
Colorectal cancer: 2.74e-4
Breast cancer: 7.39e-4
Expressed in all
MDM2MDM2 proto-oncogene, E3 ubiquitin protein ligaseCancer-related genes
Disease related genes
Predicted intracellular proteins
NucleusEndometrial cancer: 4.51e-7
Cervical cancer: 3.23e-4
Expressed in all
FZD10Frizzled class receptor 10CD markers
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
NucleoplasmEndometrial cancer: 5.05e-7
Tissue enhanced
RILPL2Rab interacting lysosomal protein-like 2Predicted intracellular proteins
CytosolEndometrial cancer: 5.24e-7
Mixed
ESR1Estrogen receptor 1Cancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Predicted intracellular proteins
Transcription factors
Nucleus
Vesicles
Endometrial cancer: 5.47e-7
Group enriched
ANAPC4Anaphase promoting complex subunit 4Predicted intracellular proteins
Intermediate filamentsEndometrial cancer: 5.73e-7
Urothelial cancer: 1.12e-6
Renal cancer: 1.17e-5
Head and neck cancer: 1.95e-4
Expressed in all
CEACAM1Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)CD markers
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Endometrial cancer: 6.32e-7
Tissue enhanced
MYDGFMyeloid-derived growth factorPlasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Renal cancer: 4.99e-12
Endometrial cancer: 6.50e-7
Expressed in all
SYTL1Synaptotagmin-like 1Plasma proteins
Predicted intracellular proteins
Endometrial cancer: 6.83e-7
Renal cancer: 1.12e-5
Mixed
B4GALT1UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Golgi apparatusEndometrial cancer: 6.85e-7
Lung cancer: 1.25e-4
Expressed in all
RPS6KA1Ribosomal protein S6 kinase, 90kDa, polypeptide 1Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol
Endometrial cancer: 7.20e-7
Renal cancer: 1.84e-4
Stomach cancer: 4.58e-4
Urothelial cancer: 8.33e-4
Mixed
LYRM1LYR motif containing 1Disease related genes
Predicted intracellular proteins
Nucleoplasm
Midbody
Endometrial cancer: 7.48e-7
Renal cancer: 4.80e-4
Urothelial cancer: 9.50e-4
Expressed in all
CD8BCD8b moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneEndometrial cancer: 7.88e-7
Renal cancer: 7.11e-6
Tissue enhanced
GLYATL2Glycine-N-acyltransferase-like 2Enzymes
Predicted intracellular proteins
MitochondriaEndometrial cancer: 9.05e-7
Group enriched
TMEM62Transmembrane protein 62Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Nucleoli fibrillar center
Nuclear bodies
Cytoplasmic bodies
Endometrial cancer: 9.72e-7
Expressed in all
SIRPGSignal-regulatory protein gammaCD markers
Predicted membrane proteins
Melanoma: 7.36e-7
Endometrial cancer: 1.05e-6
Renal cancer: 1.47e-6
Head and neck cancer: 2.24e-4
Tissue enhanced
IDNKIdnK, gluconokinase homolog (E. coli)Enzymes
Predicted intracellular proteins
Predicted secreted proteins
Mitochondria
Cytosol
Endometrial cancer: 1.10e-6
Mixed
WFS1Wolfram syndrome 1 (wolframin)Disease related genes
Plasma proteins
Potential drug targets
Predicted membrane proteins
Transporters
Endometrial cancer: 1.13e-6
Thyroid cancer: 3.13e-4
Mixed
FAM189A2Family with sequence similarity 189, member A2Predicted intracellular proteins
Predicted membrane proteins
Endometrial cancer: 1.16e-6
Renal cancer: 1.75e-5
Tissue enhanced

Page of 17 | next »